COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study
Condition:   Chronic Migraine, Headache Intervention:   Drug: Combination of Botox + CGRPmAb (Fremanezumab 225mg/1.5mL) Sponsor:   Chicago Headache Center & Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2023 Category: Research Source Type: clinical trials

Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
Conditions:   Buerger Disease;   Raynaud Syndrome Intervention:   Drug: BOTOX INJECTION Sponsor:   University Hospital, Toulouse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2023 Category: Research Source Type: clinical trials